Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

PRIVATE SALE OF EPILLO TOKEN TO GO LIVE ON 3O OCTOBER, 2022 AT 12 PM GMT


News provided by

Epillo Health Systems

Oct 27, 2022, 12:27 ET

Share this article

Share toX

Share this article

Share toX

LONDON, Oct. 27, 2022 /PRNewswire/ -- Epillo Health Systems OÜ is a company focused on consumer health and fitness solutions, founded in 2020. Through the implementation of blockchain technology, IoT, artificial intelligence and Web 3.0, the Epillo Health group aims to reduce the healthcare barriers and provide quality care, increase efficiency and access to care, and improve patient satisfaction to redefine the next era of healthcare and blockchain industry.

Continue Reading
PRIVATE SALE OF EPILLO TOKEN TO GO LIVE ON 3O OCTOBER, 2022 AT 12 PM GMT
PRIVATE SALE OF EPILLO TOKEN TO GO LIVE ON 3O OCTOBER, 2022 AT 12 PM GMT

On October 30th 2022, the company will offer an exclusive early bird sale of the EPILLO token. This is an opportunity to enter the diverse and futuristic Epillo ecosystem and contribute to their future developments at a staggering discounted price.

Soon after the formation, the company set-up its medical research wing and conducted its research on Blockchain based drug-drug interactions and drug-food interactions to reduce the adverse drug effects (ADEs) arising in the society due to multiplicity of drugs and food items being consumed in daily life. After conducting its research, in January 2021, the company filed a Patent of its technology – A Digital Therapeutics software based out of "System And Method for Blockchain Based Digital Therapeutic Devices To Predict Food-Drug Constituent Interaction". This technology assists in providing a drug interaction management tool with respect to drug-dietary interactions to help curbing ADEs, less effective medication & low drug-adherence rates. On 23.06.2022, the patent filed by the company received its initial publication vide publication no. WO 2022/132205 and was gazetted by the World Intellectual Property Organisation. On 12.03.2021, Sagacious IP, an International Consultancy, specializing in the Intellectual Property spectrum and valuations of companies, appraised the patent at a valuation of $ 150 million. Now, since the patent received its first publication from WIPO in June 2022, the valuation is expected to go up to $ 250 million in the running quarter.

Further, Epillo HealthHUB - Asia's first health, medicine and nutrition retail center was established in April 2022. This retail center offers a unique combination of a Pharmacy, Doctor Consultation, Lab Testing including detailed Genomic testing, over the counter health, fitness & wellness products along with a in-house Health-food brand, namely Freshwey. This health, medicine and nutrition wellness centre stores all the data in the form of Electronic Health Records through the mobile application – Epillo Health Mate. The HealthHUB also provides its users to avail online doctor consultation services from their home.

While the sister concern company was establishing this 'all of healthcare under one roof' center, Epillo Health Systems OÜ, began its research and development in the spectrum of blockchain based Internet of Things (IoT) in August 2022. Epillo.io was formed to represent the Blockchain vertical of Epillo Health Systems wherein the cutting-edge blockchain technology has been harnessed to develop a disruptive IoT wearable range – Fitmint Wear. The company embarked this journey through a first-of-its-kind blockchain based smartwatch - Fitmint Wear Pro coupled with the companion decentralized mobile application with features like NFT authentication, storing health data on chain, decentralized finance, NFT marketplace, health and fitness product marketplace, staking and swapping platform.

The company aims to govern this entire Epillo ecosystem through their project token – EPILLO, wherever permissible.

ABOUT THE TOKEN

Epillo Health Token (EPILLO) is the native token of Epillo Health Systems. Developed using next generation smart contract standard ERC-1155, the token will be deployed on the Polygon smart chain, an Ethereum scaling blockchain. By the end of the year, the company expects the EPILLO token to be available on multiple centralized and decentralized exchanges. Additionally,  the token will also be available for customers of the Fitmint Wear, a next generation wearable device from which users will be able to mint the token as an incentivisation mechanism to become more physically active. The total supply of the token is capped at 5 billion.

UTILITIES

As previously mentioned, one of the biggest use cases the token will have is to incentivise users of the Fitmint Wear to become more physically active through the gamification of workouts. Through this mechanism, the more calories you burn, the more EPILLO you will generate. However, this is not the only intended use for the token.  The goal of the token is to create a sustainable economy by offering multiple utilities in the entire Epillo Ecosystem (consumer healthcare, health-tech and digital health, health food and beverages, and blockchain health and fitness). EPILLO will have multiple uses, including but not limited to:

  • Purchase and powering of the Web 3.0 smartwatch.
  • Availing global health consultation and digital health services.
  • Access to gameplay in Fitmint Wear.
  • Gene/DNA testing.
  • Health and fitness e-commerce marketplace.
  • Minting NFTs and access to NFT marketplace.
  • Staking and swapping.
  • Redemption against health-food offerings.
  • Medical fundraising in the research projects.
  • Investments in retail health stores and much more!

THE GOLDEN OPPORTUNITY: PRE-SALE

With an established base in the Healthcare industry for building an entire ecosystem through state of the art technologies in the best industries, the Epillo Health Token (EPILLO) has the potential to be the "Bitcoin of the healthcare" and fitness industry. The first pre-sale of the EPILLO token will begin on "October 30th, 2022 at 12 PM GMT". For this first stage, the company expects to sell 10% of the total supply at a discounted price of $ 0.55 i.e., at a staggering discount of 33% from its premium price. Furthermore, for the benefit of the community and the investors, the EPILLO coins sold during the private sale will have a two months vesting period and the remaining will be released to the wallets 25 % each month thereafter, once this period expires. Once the private and public sale finishes, the company will initiate the listing on exchanges in December 2022 and simultaneously the Token Generation Event will take place.

To stay in touch with all the updates, please visit www.epillo.io
To get whitelisted & participate in the private sale, please visit www.epillo.io/defi 

For further queries, please contact on [email protected]

Photo: https://mma.prnewswire.com/media/1931720/Epillo_Token_Sale.jpg

SOURCE Epillo Health Systems

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.